Biologische Hochschulschriften (Goethe-Universität)
Refine
Year of publication
- 2016 (25) (remove)
Document Type
- Doctoral Thesis (24)
- Part of Periodical (1)
Language
- English (25) (remove)
Has Fulltext
- yes (25)
Is part of the Bibliography
- no (25)
Keywords
- 19F NMR shifts for fluoroarenes (1)
- Amphisphaeriales (1)
- Batten disease (1)
- Broken symmetry (1)
- Caenohalictini (1)
- DFT (1)
- Halictini (1)
- Juvenile neuronal ceroid lipofuscinosis (1)
- LINE-1 (1)
- NMR shift calculation (1)
Institute
Identification of disease modulating compounds in juvenile neuronal ceroid lipofuscinosis (JNCL)
(2016)
Mutationen im CLN3 Gen verursachen die neurodegenerative Erkrankung juvenile neuronale Zeroidlipofuszinose (JNCL). Bei dieser Erkrankung sind die Autophagie, der lysosomale pH Wert und der mitochondriale Metabolismus beeinträchtigt. Störungen dieser Prozesse führen zu einer erhöhten Verletzlichkeit neuronaler Zellen gegenüber alters- und umweltbedingten Schäden, einer Anhäufung von Autophagosomen und lysosomalem Speichermaterial, Zelltod und Neurodegeneration. Um die JNCL zu erforschen bedienen wir uns eines Zellmodels aus der Maus, welches die häufigste krankheitsauslösende CLN3 Mutation im Menschen, die Deletion der Exons 7 und 8, nachbildet. Die aus dem Kleinhirn dieser Mäuse stammenden cerebellaren Körnerstammzellen werden als CbCln3Δex7/8/Δex7/8 Zellen, solche aus wild-typ Mäusen als CbCln3+/+ Zellen bezeichnet. Die JNCL ist nicht heilbar und die Entwicklung von Wirkstoffen steht noch am Anfang.
Die vorliegende Arbeit befasst sich mit der Durchführung eines Hochdursatzscreenings um Wirkstoffe zu identifizieren, welche eine Anhäufung von Autophagosomen in CbCln3Δex7/8/Δex7/8 Zellen verhindern können. Unter 1750 verschiedenen untersuchten Wirkstoffen konnten wir 28 aktive „Hits“ identifizieren und stellten fest, dass Kalziumkanalblocker, Östrogene und HMG-CoA-Reduktase Inhibitoren gehäuft vertreten waren. Eine sorgfältige Untersuchung die möglichen Interaktionen der aktiven Wirkstoffe mit zellulären Signalwegen und die Analyse ihrer Dosis-Wirkungskurven unterstützte uns bei der Auswahl von Verapamil, Nicardipin und Fluspirilen zur näheren Untersuchung. Diese Wirkstoffe sind Kalziumkanalblocker und Fluspirilen blockt auch D2 Dopaminrezeptoren.
Außerdem untersuchten und quantifizierten wir mitochondriale Phänotypen in CbCln3Δex7/8/Δex7/8 Zellen. Unsere Untersuchungen ergaben, dass Mitochondrien in CbCln3Δex7/8/Δex7/8 Zellen einer signifikanten Hyperfusion unterliegen und ein schwächeres Membranpotenzial aufweisen. Weiterhin fanden wir eine Verringerung der maximalen der mitochondrialen Elektronentransportkapazität und eine verringerte Aktivität des Enzyms Zitratsynthase, welches die Effizienz des Zitratzyklus bestimmt.
Fluspirilen, Verapamil und, in geringerem Ausmaß, Nicardipin, verbesserten einige krankheitsbedingte lysosomale und mitochondriale Phänotypen. Des Weiteren konnten Verapamil und Nicardipin, nicht aber Fluspirilen, den erhöhten zellulären Kalziumspiegel in CbCln3Δex7/8/Δex7/8 Zellen absenken. Erniedrigungen im Kalziumgehalt können durch die Inhibition der kalziumabhängigen Protease Calpain 1 zu einer Induktion der Autophagie führen. Wir untersuchten, ob eine chemische Inhibition der Calpain 1-Protease die Anzahl der Autophagosomen in CbCln3Δex7/8/Δex7/8 Zellen senkt, und stellten fest, dass dies nicht der Fall ist. Eine Inhibition von Calpain 1 führte lediglich zu einem Anstieg der Zahl zellulärer Autophagosomen. Als Nächstes untersuchten wir die Auswirkung der Wirkstoffbehandlung auf den Autophagiefluss. Verapamil und Nicardipin hatten keinen Einfluss auf den Autophagiefluss in der getesteten Konzentration in CbCln3Δex7/8/Δex7/8 Zellen während Fluspirilen die Autophagie induzierte. Gleichzeitig stellten wir fest, dass hohe Dosen von Nicardipin und Verapamil teilweise vor einem Verlust des lysosomalen pH-Werts durch eine Behandlung mit Bafilomycin A1 schützen konnten. Da Fluspirilen auch ein Dopaminrezeptorblocker ist, untersuchten wir die Auswirkung einer erhöhten Dosis von Dopamin auf die Zahl der Autophagosomen. Wir fanden, dass eine mittlere Dosierung von Dopamin einen Trend zu einer leichten Verringerung von Autophagosomen in CbCln3Δex7/8/Δex7/8 Zellen zur Folge hat.
Wir vermuten, dass die Kalziumkanalblocker Verapamil und Nicardipin und der Dopaminrezeptorblocker Fluspirilen unterschiedliche zelluläre Signalwege benutzen, aber letztendlich um ähnliche Botenstoffe verwenden, um die Funktion der Lysosomen in CbCln3Δex7/8/Δex7/8 Zellen zu verbessern. Die Verringerung des intrazellulären Kalziumgehalts durch Verapamil und Nicardipin führt zu einer Aktivierung von Adenylatzyklasen, welche eine Erhöhung des intrazellulären cAMP Spiegels herbeiführen. Fluspirilen inhibiert Dopaminrezeptoren vom Typ D2 (D2DR), was zu einer selektiven Aktivierung von Dopaminrezeptoren des Typs D5 (D5DR) führen könnte. Im Gegensatz zu D2 führen D5D Rezeptoren zu einer Aktivierung von Adenylatzyklasen und einer Erhöhung des cAMP Spiegels. cAMP aktiviert die Protein Kinase A (PKA), welche durch eine Proteinphosphorylierung von lysosomalen Chloridkanälen und Protonenpumpen die lysosomale Aktivität erhöht. Dies führt zu einer Verbesserung des Abbaus von Autophagosomen und lysosomalem Speichermaterial und zu einer verbesserten Zellgesundheit in CbCln3Δex7/8/Δex7/8 Zellen.
Eine Verbesserung der lysosomalen Funktion in der JNCL kann einen wirksamen Therapieansatz ergeben. Wir hoffen, dass die hier vorgestellten Methoden und Ergebnisse einen ersten Schritt in diese Richtung darstellen.
Juvenile neuronal ceroid-lipofuscinosis (JNCL) is a rare lysosomal storage disease in children with lethal outcome and no therapy. The origin of JNCL has been traced to autosomal recessive mutations in the CLN3 gene, and ~85% of the JNCL patients harbor a 1.02 kb deletion that removes the exons 7 and 8 and the surrounding intronic DNA (CLN3Δex7/8). So far, structure, function and localization of the CLN3 protein remain elusive. However, there is strong evidence that CLN3 modulates a process or condition that is essential in many cellular pathways. Lipid metabolism and antero-/retrograde transport, two mechanisms CLN3 was previously implicated in, fulfill these requirements. Notably, also a bioactive group of glycosphingolipids referred to as gangliosides is tightly interrelated with these functions. Furthermore, a-series gangliosides have been shown to be involved in the development and sustenance of the brain, where they are essential for neurite outgrowth and cell survival. Defects in ganglioside metabolism were shown to play a crucial role in many lysosomal storage disorders. However, the contribution of gangliosides to NCL pathology is largely unknown.
The present study analyzed central enzymes and metabolites of the a-series ganglioside pathway in a JNCL cell model. The core finding was, thereby, the reduced amount of the neuroprotective ganglioside GM1 in homozygous CbCln3Δex7/8 cells. This was caused by the enhanced action of the GM1-degrading multimeric enzyme complex and in particular, by the upregulation of protein levels and increased enzyme activity of β-galactosidase (Glb1).
Improved binding of Glb1 to substrate-carrying membranes was provided by an increase in LBPA levels. In combination with other smaller alterations in the ganglioside pattern, a shift towards less complex gangliosides became present. The resulting loss of neuroprotection may be the reason for the multifocal pathology in homozygous CbCln3Δex7/8 cells.
The second part of the present study investigated the cellular mechanisms behind the altered ganglioside profile with regard to the potential role of CLN3. Here, the anterograde transport of GM1 to the plasma membrane presented a positive correlation with the amount of full-length CLN3. In case of the truncated protein this correlation was missing, resulting in reduced PM staining with CTxB-FITC. However, transfection of full-length CLN3 in these cells restored the CTxB-FITC intensity. Based on the neuroprotective role of GM1, the corresponding increase in GM1 levels may be the cause for the restoration effects observed in previous studies using full-length CLN3. Hence, administration of GM1 was expected to improve cell viability of homozygous CbCln3Δex7/8 cells and beyond that to rescue potentially some disease phenotypes. However, no effect could be observed. The reason for this may be reduced caveolar uptake and the mislocalization of ganglioside GM1 to the trans-Golgi network (TGN) and redirection towards degradative compartments.
Both are in line with the idea of an impaired endocytic flux in CLN3 deficiency. The observed localization of CLN3 in the TGN suggests a potential role for CLN3 in the lipid sorting machinery, subsequently altering membrane composition and its regulatory functions. The resulting imbalance may affect many of the cellular processes impaired in JNCL.
Recently, two of the most common types of bone cancers in children and young adults have been proven to exhibit vulnerability to poly(ADP)-ribose polymerase, (PARP) inhibitors (e.g. olaparib, talazoparib). Ewing’s sarcoma (ES) are reported to harbor a fusion gene EWS-FLI1 (85%), inducing tumorigenesis. Additional, as the fusion gene acts as aberrant transcription factor, it similarly induces elevated PARP expression levels sensitizing ES to PARP inhibition. Second, by an exome sequencing approach in a set of primary osteosarcomas (OS) we identified mutation signatures being reminiscent of BRCA deficiency. Therefore, the sensitivity of a panel of OS cell lines to either talazoparib single treatment or in combination with several chemotherapeutic drugs was investigated.
To screen ES tumor cell lines against PARP inhibitors we applied four different PARP inhibitors (talazoparib, olaparib, niraparib and veliparib) that are frequently being used for clinical studies. We combined those PARP inhibitors with a set of chemotherapeutics (temozolomide (TMZ), SN-38, etoposide, ifosfamide, doxorubicin, vincristine and actinomycin D) that are part of the first-line therapy of ES patients. Here, we demonstrate how PARP inhibitors synergize with TMZ or SN-38 to induce apoptosis, whereas the combination of PARP inhibitors with the other drugs are not favorable. By investigation of key checkpoints in the molecular mechanisms of cell death, the pivotal role of the mitochondrial pathway of apoptosis mediating the synergy between olaparib and TMZ was revealed.
Employing talazoparib monotherapy in combination with or without several chemotherapeutic drugs (TMZ, SN-38, cisplatin, doxorubicin, methotrexate and etoposide/carboplatin), the correlation between homologous recombination (HR) repair deficiency (BRCAness) and the response to talazoparib as prototypical PARP inhibitor was validated in different OS cell lines. By calculation of combination indices (CI) and fraction affected (Fa) values, we identified TMZ as the most potent chemotherapeutic drug in combination with talazoparib inducing the mitochondrial apoptotic pathway in OS.
In our studies of two independent tumor entities with contrary genetic background we identified the combination of PARP inhibitor and TMZ as being most effective. Our studies point out that after TMZ induced DNA methylation and concomitant PARP trapping, DNA damage-imposed checkpoint kinase activation consequently induces G2-cell cycle arrest. Subsequent, PARP inhibitor/TMZ causes MCL-1 degradation, followed by activation of BAK and BAX, succeeding in loss of mitochondrial outer membrane potential (LMMP) and activation of downstream effector-caspases in mitochondrial apoptosis. Our findings emphasize the importance of PARP inhibition in order to chemosensitize ES, which express high PARP levels, or OS that bear features of BRCAness.
The transition from the marine to the terrestrial realm is one of the most fascinating issues in evolutionary biology for it required the appearance, in different organisms, of several novel adaptations to deal with the demands of the new realm. Adaptations include, for instance, modifications in different metabolic pathways, development of body structures to facilitate movement and respiration, or tolerance to new conditions of stress. The transition to the land also gives an extraordinary opportunity to study whether evolution used similar changes at the genomic level to produce parallel adaptations in different taxa. Mollusks are among taxa that were successful in the conquest of the land. For instance, several lineages of the molluscan clade Panpulmonata (Gastropoda, Heterobranchia) invaded the intertidal, freshwater and land zones from the marine realm. In my dissertation, using tools from bioinformatics, phylogenetics, and molecular evolution, I used panpulmonates as a suitable model group to study the independent invasions into the terrestrial realm and the adaptive signatures in genes that may have favored the realm transitions. My work includes two peer-reviewed published papers and one manuscript under review. In Publication 1 (Romero et al., 2016a), I used mitochondrial and nuclear molecular markers to resolve the phylogeny of the Ellobiidae, a family that possesses intertidal and terrestrial species. The phylogeny provided an improved resolution of the relationships within inner clades and a framework to study the tempo and mode of the land transitions. I showed that the terrestrialization events occurred independently, in different lineages (Carychiinae, Pythiinae) and in different geological periods (Mesozoic, Cenozoic). In addition, the diversification in this group may not have been affected by past geological or climate changes as the Cretaceous-Paleogene (K-Pg) event or the sea-level decrease during the Oligocene. In Publication 2 (Romero et al., 2016b), I generated new mitochondrial genomes from terrestrial species and compared them with other panpulmonates. I used the branch-site test of positive selection and detected significant nonsynonymous changes in the terrestrial lineages from Ellobioidea and Stylommatophora. Two genes appeared under positive selection: cob (Cytochrome b) and nad5 (NADH dehydrogenase 5). Surprisingly, I found that the same amino acid positions in the proteins encoded by these genes were also under positive selection in several vertebrate lineages that transitioned between different habitats (whales, bats and subterranean rodents). This result suggested an adaptation pattern that required parallel genetic modifications to cope with novel metabolic demands in the new realms. In Manuscript 1 (Romero et al., under review), I de novo assembled transcriptomes from several panpulmonate specimens resulting in thousands of genes that were clustered in 702 orthologous groups. Again, I applied the branch-site test of positive selection in the terrestrial lineages from Ellobioidea and Stylommatophora and in the freshwater lineages from Hygrophila and Acochlidia. Different sets of genes appeared under positive selection in land and freshwater snails, supporting independent adaptation events. I identified adaptive signatures in genes involved in gas-exchange surface development and energy metabolism in land snails, and genes involved in the response to abiotic stress factors (radiation, desiccation, xenobiotics) in freshwater snails. My work provided evidence that supported multiple land invasions within Panpulmonata and provided new insights towards understanding the genomic basis of the adaptation during sea-to-land transitions. The results of my work are the first reports on the adaptive signatures at the codon level in genes that may have facilitated metabolic and developmental changes during the terrestrialization in the phylum Mollusca. Moreover, they contribute to the current debate on the conquest of land from the marine habitat, a discussion that has been only based in vertebrate taxa. Future comparative genome-wide analyses would increase the number of genes that may have played a key role during the realm transitions.
The lung comprises more than 40 different cell types, from epithelial cells to resident mesenchymal cells. These cells arise from the foregut endoderm and differentiate into specialized cell types that form the respiratory and conducting airways, and the trachea. However, the molecular pathways underlying these differentiation processes are poorly understood, and may be relevant to pathological conditions. According to the World Health Organization (WHO), while the respiratory disease rate is increasing, limited treatment and therapies are available. Thus, there is a growing need for new treatment strategies and alternative therapies. Various in vivo and in vitro studies in the model organism mus musculus have already provided valuable information on lung cell lineages and their differentiation and/ or dedifferentiation during development and pathological conditions. However, there remain many questions regarding the key regulators and molecular machinery driving lung cell differentiation and underlying lung progenitor/stem cell biology.
Aiming to develop new animal models for lung diseases, we used a forward genetic careening approach, which provides an unbiased method for identifying genes with important roles in lung cell differentiation, and thus probable contributors to pathological conditions. We conducted an N-ethyl-N-nitrosourea (ENU) mutagenesis screen in mice and used several histological and immunohistochemical approaches to identify and isolate mutants, focusing on mutations associated with cell differentiation rather than those affecting early development and patterning of the respiratory system. Thus, we screened for phenotypes in the respiratory system of pups from the F2 generation at postnatal day 7 and 0 (P7; P0). I specifically screened 114 families. Each F1 male animal is the founder of 5 to 6 F2 female daughters. For each family, at least 4 F2 females per male founder were analyzed. In total, I screened 630 litters at P7 and P0 with 7 pups on average for each litter. As a result of this extensive screening, 11 different phenotypes in 42 different F2s were discovered at primary screen and later just 2 phenotypes recovered in F3 generation of identified carriers. To identify the causative genes for each of these phenotypes, whole exome sequencing will be conducted in the future to identify recurring SNPs; these can subsequently be linked causatively to the resultant phenotype(s) via complementation studies. In turn, these linkages would enable the creation of mutant mice using CRISPR/Cas9 genomic engineering, which would be invaluable to the further study of respiratory development and disease.
The development of the atrioventricular (AV) canal and the cardiac valves is tightly linked and a critically regulated process. Anomalies in components of the involved pathways can lead to congenital valve malformations, a leading cause of morbidity and mortality in neonates. Myocardial Bmp as well as endocardial Notch and Wnt signaling have been identified as critical factors for the induction of EMT during the formation of the endocardial cushions and cardiac valves. Of these, canonical Wnt signaling positively regulates endocardial proliferation and EMT but negatively regulates endocardial differentiation. Further, elevated Wnt signaling leads to the ectopic expression of myocardial Bmp ligands suggesting a high level of integration of the involved pathways and crosstalk amongst the different cardiac tissues.
Here we have identified a novel role for Id4 as a mediator between Bmp and Wnt signaling. Id4 belongs to the Id family of proteins and is known to be involved in bone and nervous system development. We found that in zebrafish, id4 is expressed in the endocardium of the AV canal at embryonic stages and throughout the atrial chamber in addition to AV canal, in adults. Using transcription activator-like effector nucleases (TALENs) we established an id4 mutant allele. Our analysis shows that id4 mutant larvae are susceptible to retrograde blood flow, and show aberrant expression of developmental valvular markers. These include expanded expression domains of markers like bmp4, cspg2a and Alcam. In contrast, valve maturation as assessed by the expression of spp1 is considerably reduced in id4 mutants. Using conditional transgenic systems, along with elegant in vivo imaging of transgenic reporter lines, we further found that id4 is a transcriptional target of Bmp signaling, and it is capable of dose dependently restricting Wnt signaling in the endocardium of the Atrioventricular Canal.
Taken together, our data identifies Id4 as a novel player in Atrioventricular Canal and valve development. We show that Id4 function is important in valve development acting downstream of Bmp signaling by restricting endocardial Wnt to allow valve maturation
Fungi are an important component of every ecosystem but hardly considered in biodiversity monitoring projects. This thesis aims at characterizing fungal diversity, with an emphasis on epigeous fungi, encompassing different biogeographic zones and points in time. A main sampling area was established in the Taunus mountain range in Germany, which was sampled monthly over three years.
For testing species richness on spatial scale, the Taunus transect was compared with four other areas, which were assessed with lower sampling effort. One of these areas was Bulau in Germany, in which four excursions were made. Furthermore, two sampling events were performed in Somiedo in Spain and one sampling event in Kleinwalsertal in Austria. Already existing data of a two-year monitoring project in Panama next to the river Majagua were additionally used for comparison.
All these areas were investigated with a standardized sampling protocol focusing on macroscopically evident fungi and vascular plants using a time-restricted transect design. The transects consisted of strips, which were 500 m long and about 20 m broad, and were sampled for 2 hours at each single sampling event....
Xenorhabdus and Photorhabdus bacteria are gaining more and more attention as a subject of research because of their unique yet similar life cycle with nematodes and insects. This work focused on the secondary metabolites that are produced by Xenorhabdus and Photorhabdus. With the help of modern HPLC-MS methodologies and increasingly available bacterial genome sequences, the structures of unknown secondary metabolites could be elucidated and thus their biosynthesis pathways could be proposed, too.
The first paper reported 17 depsipeptides termed xentrivalpeptides produced by the bacterium Xenorhabdus sp. 85816. Xentrivalpeptide A could be isolated from the bacterial culture as the main component. The structure of xentrivalpeptide A was elucidated by NMR and the Marfey´s method. The remaining xentrivalpeptides were exclusively identified by feeding experiments and MS fragmentation patterns.
The second paper described the discovery and isolation of xenoamicin A from Xenorhabdus mauleonii DSM17908. Additionally, other xenoamicin derivatives from Xenorhabdus doucetiae DSM17909 were analyzed by means of feeding experiments and MS fragmentation patterns. The xenoamicin biosynthesis gene cluster was identified in Xenorhabdus doucetiae DSM17909.
The manuscript for publication focused on the biosynthesis of anthraquinones in Photorhabdus luminescens. The Type II polyketide synthase for the biosynthesis of anthraquinone derivatives was discovered in P. luminescens in a previous publication by the Bode group,1 in which a partial reaction mechanism for the biosynthesis has been proposed. The manuscript reported in this thesis however elucidated the biosynthetic mechanisms in a greater detail as compared to the previous publication. Particularly, the biosynthetic mechanism was deciphered through heterologous expression of anthraquinone biosynthesis (ant) genes in E. coli. Additionally, deactivation of the genes antG encoding a putative CoA ligase and antI encoding a putative hydrolase, was performed in P. luminescens. Selected ant genes were over-expressed in E. coli as well as the corresponding proteins purified for in vitro assays. Model compounds were chemically synthesized as possible substrates of AntI and were used for in vitro assays. Here, it was revealed that the CoA ligase AntG played an essential role in the activation of the ACP AntF. Furthermore, a chain shortening mechanism by the hydrolase AntI was identified and was further confirmed by in vitro assays using model compounds. Additionally, this chain shortening mechanism was supported by homology based structural modeling of AntI.
Tulasnella species (Tulasnellaceae, Cantharellales, Basidiomycota) form inconspicuous basidiomata on rotten branches or trunks of trees, difficult to find and recognize in nature. However, according to ultrastrucural and molecular data, species of Tulasnellaceae are the most frequent mycorrhriza forming fungi (mycobionts) of green, photosynthetic orchids worldwide. Species of Tulasnellaceae were also found as prominent mycobionts of the extraordinary diverse orchids in tropical montane rainforest of Southern Ecuador. Orchids obligately depend on mycobionts during the juvenile stage when the fungi have to deliver carbon to the non-photosynthetic protocorm and thus the fungi substantially influence the establishment of orchids in the wild. Species of Tulasnellaceae can acquire carbon from decaying bark or wood by specific saprotrophic capabilities as was recently proven through comparative genomics that included data on decay enzymes from Tulasnella cf. calospora isolated from orchid mycorrhizae (Anacamptis laxiflora, Italy). Thus, species of Tulasnellaceae can be saprotrophs and symbionts simultaneously.
It is currently under discussion, whether specific species of Tulasnella are required for seed germination and establishment of distinct terrestrial and epiphytic orchids in nature or if species of Tulasnella are generalists concerning their association with orchids. The inconsistences in species concepts and taxonomy of Tulasnella spp., however, strongly impede progress in this field of research. The aim of the present study was, therefore, to revise the species concepts by combining, for the first time, morphological and molecular data from basidiomata.
Specimens were collected in tropical Andean forest in Southern Ecuador and in temperate forests in Germany. Additional specimens were loaned from fungaria. In total, 205 specimens, corresponding to 16 own samples and 189 specimens from fungaria were analyzed. The mycobiont relationships of Tulasnella spp. with orchids from the sampling area in Ecuador were studied in populations of Epidendrum rhopalostele. The basis for molecular-phylogenetic analysis was completed by data obtained from own previous investigations on mycobionts from the investigation area and Tulasnella isolates from Australia.
30 morphospecies are illustrated and delimited by a morphological key based on traditional species concepts. Tulasnella andina from Ecuador and Tulasnella kirschneri from China are presented as species new to science. Tulasnella cruciata is described from herbarium material for the first time. Tulasnella aff. eichleriana and T. violea are reported for the first time from Ecuador. Molecular sequences of two Tulasnella spp. isolated from mycobionts of Epidendrum rhopalostele cannot be related to any morphological species concept. Statistical analyses suggest that conventional diagnostic using morphological characteristics is ambiguous for delimiting morphologically similar species.
For the first time sequences of the ITS-5.8S rDNA region were obtained after cloning from fresh basidiomata. Extraction of DNA from herbarium specimens was, however, unsuccessful. Sequences from 16 fresh basidiomata, six pure cultures, and sequences of orchids mycorrhizae (e.g. from Epidendrum rhopalostele) available in the database GenBank were analyzed. Proportional
variability of ITS-5.8S rDNA sequences within and among cultures and within and among specimens were used to designate morphospecies. Results suggest an intragenomic variation of less than 2 %, an intraspecific variation of up to 4 % and an interspecific divergence of more than 9 % for Tulasnella spp.
Four percent of intraspecific divergence was defined as a minimum threshold for delimiting phylogenetic species. This threshold corroborates the so far used 3 % to 5 % divergence in delimitation of operational taxonomic units of Tulasnella mycobionts.
Quite a number of sequences of Tulasnella are available in GenBank, mostly obtained from direct PCR amplification from orchid mycorrhizae. By including closely related sequences in the phylogenetic analysis, several morphological cryptic species of Tulasnella, mostly from Ecuador, were found. Arguments are given for molecular support of the new species Tulasnella andina and the established species Tulasnella albida, T. asymmetrica, T. eichleriana, T. tomaculum, and T. violea. Thus, by combining molecular and morphological data species concepts in Tulasnella are improved. The definitions of Tulasnella calospora and T. deliquescens, however, remain phylogenetically inconsistent.
The present investigation is a first step to expand our knowledge on the intraand interspecific morphological and molecular variability of Tulasnella spp. and to delimit species relevant for studies on ecology and communities of orchids and Tulasnellaceae.
The human Long Interspersed Nuclear Element-1 (LINE-1, L1) is a member of the group of autonomous non-LTR retrotransposons found in almost every eukaryotic genome. L1 elements generate copies of themselves by reverse transcription of an RNA intermediate and integrate into the host genome by a process called Target Primed Reverse Transcription (TPRT). They are responsible for the generation of approximately 35% of the human genome, cover about 17% of the genome and represent the only group of active autonomous transposable elements in humans. L1 activity bears several risks for the integrity of the human genome, since the L1-encoded protein machinery generates DNA double-strand breaks (DSBs) and is capable of conducting numerous genome-destabilizing effects, e.g. causing deletions at insertion sites, disrupting or rearranging coding sequences and deregulating transcription of functional host genes. On the other side, L1 elements have had and still exert a great impact on human genome structure and evolution by increasing the genome size and rearranging and modulating gene expression. Furthermore, due to its endogenous and generally non-pathogenic nature, L1 is a promising candidate as vector for gene delivery in somatic gene therapy. The structure of the flanking regions between de novo L1 integrants and the genomic sequence suggests an involvement of cellular DSB repair pathways in L1 mobilization. To elucidate the role of DSB repair proteins in L1 retrotransposition, I disabled DSB repair factors ATM, ATR, DNA-PK, p53 and Ku70 by knock down (KD) using short hairpin RNA (shRNA) expression constructs. To inhibit the function of DSB repair factors PARP and Rad51, I used dominant negative (DN) PARP and Rad51 mutants. Applying a well established L1-retrotransposition reporter assay in HeLa cells, de novo retrotransposition events were launched in order to test L1 for its retrotransposition activity in the context of altered DSB repair conditions. I could show that L1 retrotransposition frequency after ATM KD had increased by 3-fold, while ATR and p53 KD reduced L1 retrotransposition by approximately one third. Unfortunately, the cytotoxic effects of the DNA-PK and Ku70 shRNA expression constructs were too strong to determine potential effects of DNA-PK and Ku70 KD on L1 retrotransposition. Inhibition of PARP function by expression of the DN mutant and overexpression of wild type PARP were found to increase L1 retrotransposition by 1.8 and 1.5, respectively, while Rad51 DN had no detectable effect. Interestingly, overexpression of wild type Rad51 seemed to roughly double L1 retrotransposition frequencies. Since in my experiments KD or expression of DN mutants was time-delayed to the onset of L1 retrotransposition after transfection into the cells, I developed a temporally controllable, tetracyclin transactivator (tTA)-dependent L1 retrotransposition reporter assay which will be of great value for future L1 retrotransposition studies that rely on temporally controllable retrotransposition. Due to a previously published hypothesis of L1 playing a role in brain development by contributing to somatic mosaicism in neuronal precursor cells, I generated a transgenic mouse (LORFUS) using the tTA-dependent L1 construct to further test this hypothesis. LORFUS harbors a bidirectional cassette driving simultaneous expression of a GFP-tagged L1 retrotransposition reporter and beta-galactosidase. It was bred to another transgenic mouse line expressing tTA in the forebrain. The double transgenic offspring was used to characterize L1 expression and retrotransposition patterns in the brain at postnatal day 15 (P15). General transgene expression indicated by beta-galactosidase activity was found in hippocampus, cortex and striatum, while retrotransposition events revealed by GFP expression were found in hippocampus, cortex, striatum, olfactory bulb and brainstem. These results suggested L1 retrotransposition in the granule layer of the dentate gyrus earlier than P15 and migration of cells carrying these events along the rostral migratory stream into the olfactory bulb. To facilitate the use of L1 as gene delivery tool in gene therapy or genetic engineering, I furthermore intended to manipulate the L1 target site recognition to allow the site-specific integration into defined genomic locations. To this end, I performed crystal structure-guided mutational analysis exchanging single amino acid residues within the endonuclease (EN) domain of L1 to identify residues influencing target site recognition. However, individual point mutations did not change the nicking pattern of L1-EN, but resulted in a reduction of endonucleolytic activity reflected by a reduced retrotransposition frequency. This suggests that additional factors other than the DNA nicking specificity of L1-EN contribute to the targeted integration of non-LTR retrotransposons in the host genomes.